Novartis is planning to spin off its generics-and-biosimilars division Sandoz and list it as a stand-alone…
Tag: Biopharmaceuticals
Moderna Asks FDA to OK Updated Covid-19 Shot
Moderna Inc. has asked U.S. regulators to authorize a new version of its Covid-19 vaccine that…
Pfizer, BioNTech Ask FDA to Green Light Tweaked Covid-19 Vaccine
This copy is for your personal, non-commercial use only. Distribution and use of this material are…
Biotech Rebounds on Optimism and Deal Making
Listen to article (2 minutes) Biotech stocks, some of the biggest losers in the selloff, are…
FDA Approves Bluebird’s $2.8 Million Gene Therapy for Rare Blood Disease
The Food and Drug Administration approved a gene therapy from Bluebird Bio Inc. that represents a…
Biotech Startup Cerevance Strikes Alzheimer’s Research Deal With Merck
Biotechnology startup Cerevance Inc. could earn more than $1 billion through a collaboration with drugmaker Merck…
Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics
Updated Aug. 8, 2022 7:11 am ET Pfizer Inc. has agreed to buy Global Blood Therapeutics…
WSJ News Exclusive | Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved…